Rheumatology News
- FDA Safety Changes: Janumet, WelChol, Rituxan
- Sulfasalazine for Rheumatoid Arthritis May Cause Severe Hepatotoxicity
- Abatacept Shows Ongoing Benefit in Arthritis Patients
- Guidelines Issued for Screening Men for Osteoporosis
- Height Loss Measurement Improves Sensitivity of Osteoporosis Diagnosis
- Recalls & Warnings Etanercept Gets Black Box Warning for TB Risk
- Anti-TNF Drugs Equivalent for Treatment of Rheumatoid Arthritis
- Misdiagnoses Caused in Part by Overconfidence
- Osteoporosis Drug Promotes Atrial Fibrillation in Population-Based Study
- Urate Slows Progression of Parkinson's Disease
- Review Addresses Strategies for Patient Adherence to Medications
- Major Organ Involvement Common in Children With SLE
- Non-Hodgkin Lymphoma Risk Increased by Some Autoimmune Disorders
- Recombinant IgG Fc More Potent Than Native IVIG
- FDA Approval: Orencia
- Vioxx Critique Will Not Scuttle Merck Settlement
- Methotrexate and Isoniazid Safe in Rheumatoid Arthritis Patients With TB
- Japan Approves Roche's Drug Actemra for Arthritis
- Vioxx Documents Offer Glimpse Into Ghostwritten Manuscripts, "Hire-A-PI," and Data Manipulation
- TNF Gene Polymorphisms Linked to Adalimumab Response in Rheumatoid Arthritis
Sign Up: 
Daily News Email
Daily News EmailTop Stories
- Recalls & Warnings Etanercept Gets Black Box Warning for TB Risk
- Anti-TNF Drugs Equivalent for Treatment of Rheumatoid Arthritis
- Recalls & Warnings Serious Skin Reactions Reported With TNF-alpha Antagonists
- Recalls & Warnings Black Box Warning Issued for Etanercept Regarding Infections